Quality Improvement for Institutions
www.cvquality.acc.org
  1. Home
  2. News

What's New at NCDR and ACC Accreditation Services

Stay up to date with the latest news from ACC NCDR and Accreditation Services, where data, accreditation and collaboration come together to drive meaningful improvements in cardiovascular care.

Celebrating Ten Years of Excellence

As ACC NCDR and Accreditation Services celebrates 10 years together, we reflect on a decade of progress, collaboration, and measurable improvement in cardiovascular care. Together with our partners, we remain focused on driving innovation, quality, and better outcomes for patients nationwide.

New Accreditation Designation

10 Years Together

NEW Chest Pain Center Accreditation Cardiogenic Shock Designations!

New standards focused on early recognition and escalation of cardiogenic shock. Presales will be available in late spring 2026. Stay tuned for tools and resources to support your planning.

News Stories and Journal Scans

Explore the latest ACC NCDR and Accreditation articles and stay informed about updates, insights and key developments.

CMS Proposes Updates to TAVR National Coverage Determination

View Article

ACC Streamlines Cardiac Accreditation for Hospital Systems

View Article

ACC HeartCARE Center Designation Hits 100 Hospital Milestone

View Article

NCDR Study: Prevalence and Outcomes of PCI Performed at Facilities Without On-Site Cardiac Surgery

View Article

NCDR Study: Off-Label Transcatheter Tricuspid Valve Interventions Demonstrate Reduced Residual TR, Improved QOL

View Article

QI.PI Project Grant Recipient Develops Digital Biomarker for PAD Screening


View Article

Stay Connected to Quality and Practice Excellence

U.S. News and World Report

In the 2026 U.S. News and World Report "Best Hospitals" issues annual ad insert, the ACC recognizes the more than 2,000 hospitals, health systems and centers participating in NCDR and/or Accreditation Services.

 

ACC CV Quality SmartBrief

The ACC CV Quality SmartBrief eNewsletter is a free, twice-weekly briefing for health care stakeholders interested in quality care.

Learn more about the ACC CV Quality SmartBrief and subscribe.

Connect Through DocMatter

ACC members can deepen their engagement through DocMatter, the College's exclusive, secure online community. DocMatter connects over 65,000 cardiovascular professionals to provide a trusted space to exchange insights, discuss clinical and operational challenges, and stay informed about ACC NCDR and Accreditation programs and initiatives.

ACC members can access DocMatter as part of their membership.

From The ACC

Explore the latest news and insights from the American College of Cardiology shaping cardiovascular quality, care delivery, and accreditation.

  • AHRQ launches $7.95M challenge for AI in healthcare

    The Agency for Healthcare Research and Quality has launched the $7.95 million Super Intelligence for Healthcare Improvement Initiative to speed medical evidence reviews and expand the use of federal healthcare data. The initiative includes the Clinical Evidence Synthesis Transformation Challenge, which offers up to $5.85 million in prizes for tools that can evaluate medical evidence quickly. The SI Tech Sprint for Healthcare Research and Implementation Quality and Safety is focused on using AHRQ databases for research and patient safety applications. Becker's Hospital Review (10/7) Learn More

  • GLP-1 drugs may be linked to fewer HF hospitalizations

    A study presented at a Heart Failure Society of America meeting indicates that GLP-1 agonists and dual GLP-1/GIP agonists can significantly reduce pulmonary artery pressure in individuals with heart failure. The retrospective analysis, which used data from patients with the CardioMEMs system, found substantial reductions in systolic and mean PA pressures, decreased use of loop diuretics and fewer hospitalizations for heart failure. HCPLive Network (10/11) Learn More

  • High incidence of respiratory infections post-CAR T-cell therapy

    A study in the International Journal of Infectious Diseases found that 46% of patients receiving chimeric antigen receptor T-cell therapy for lymphoma or myeloma developed respiratory viral infections, with most cases occurring after 100 days post-infusion. Patients with low absolute lymphocyte counts and CD19+ B-cell counts were at higher risk for severe infections. Medscape (10/8) Learn More

  • A checklist for rural hospitals negotiating payer contracts

    Disputes with Medicare Advantage and commercial health plans, including terminated contracts and unsustainable reimbursement rates, put pressure on rural hospitals' finances and ability to provide care, write healthcare litigation experts Mackenzie Wallace and Ashton Dietrich. Rural hospitals may feel small and powerless, but they do have some regulatory leverage. State-level protections and network adequacy requirements can provide strategic advantages in negotiations. Wallace and Dietrich provide a checklist for rural hospitals responding to disputes or threats of contract termination. Chief Healthcare Executive (10/9) Learn More

  • Cybersecurity in healthcare shifts toward resilience

    Healthcare organizations are focusing on resilience and continuity as cyberattacks increasingly affect clinical operations. A 2021 ransomware attack at Scripps Health highlighted the regional impact of such incidents, impacting patient outcomes and operational capacity at nearby hospitals. Elliot Jones of Kaiser Permanente and Jeff Tully of the UC San Diego Center for Healthcare Cybersecurity emphasize the need for systems that minimize the consequences of human error. AI presents both opportunities and risks in cybersecurity, and organizations must be deliberate in its implementation. Healthcare Innovation (10/12) Learn More

  • Few FDA-cleared AI devices tested for patient outcomes

    A study in PLOS Digital Health raises concerns about the clinical evidence supporting AI medical devices in the US. The study found that of 1,357 devices approved by the FDA, only three had been evaluated for patient-centered outcomes including complications, mortality and hospital readmission. Most devices were cleared through the FDA's 510(k) pathway, which does not require extensive clinical trials. The study highlights the need for better evidence as AI becomes more integrated into healthcare. Yahoo (10/5) Learn More

  • FDA approves heart valve that grows with pediatric patients

    The FDA has approved the Autus Size-Adjustable Valve, a heart valve designed to grow with pediatric patients who have congenital pulmonary valve disease, potentially reducing the need for multiple open-heart surgeries. The valve, which can be expanded from 13 millimeters to 22 using a balloon, is the first to use synthetic material for its leaflets and showed success in a study of 62 children, with no major complications reported. HealthDay News (10/2) Learn More

Temp Styles

American College of Cardiology: 2400 N St. NW, Washington DC 20006